Corbus Pharmaceuticals Holding

Market Cap

$144M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$7.56-$0.31 (-3.94%)

Jun 5, 2026

52W High $19.3652W Low $6.90

Company Details

Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer ce...

CEO

—

IPO Date

Nov 11, 2014

Website

www.corbuspharma.com

Key Metrics TTM

Revenue

-100.0% YoY

Net Income

-$85M

EPS (Diluted)

Free Cash Flow

-$74M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q2 2026

Aug 11, 2026

PENDING

Q1 2026

May 12, 2026

FY 2025

Mar 9, 2026

Q4 2025

Mar 9, 2026

$0-100.0%

Q3 2025

Nov 12, 2025

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee